Related references
Note: Only part of the references are listed.3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism
Ina Lehmphul et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
The Striosome and Matrix Compartments of the Striatum: A Path through the Labyrinth from Neurochemistry toward Function
Katherine R. Brimblecombe et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior
Jian-Feng Liu et al.
JOURNAL OF NEUROSCIENCE (2017)
Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process
Elena Cichero et al.
FUTURE MEDICINAL CHEMISTRY (2017)
The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice
Annunziatina Laurino et al.
HORMONES AND BEHAVIOR (2017)
Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines
Grazia Chiellini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Mark D. Berry et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum
Carmelo Sgobio et al.
SCIENTIFIC REPORTS (2017)
3-iodothyronamine, a novel endogenous Modulator of Transient Receptor Potential Melastatin 8?
Noushafarin Khajavi et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
The emerging roles of human trace amines and human trace amine- associated receptors (hTAARs) in central nervous system
Muhammad Zahid Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors
Annunziatina Laurino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
Mark J. Millan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum
Armando G. Salinas et al.
NEUROPHARMACOLOGY (2016)
Increased context-dependent conditioning to amphetamine in mice lacking TAAR1
Ilya Sukhanov et al.
PHARMACOLOGICAL RESEARCH (2016)
Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions
Carolin Stephanie Hoefig et al.
THYROID (2016)
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
Yue Pei et al.
FRONTIERS IN NEUROSCIENCE (2016)
In-vivo pharmacology of Trace-Amine Associated Receptor 1
Vincent M. Lam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine
Annunziatina Laurino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers
Anja Harmeier et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling
Juliane Dinter et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
Alexandra Alvarsson et al.
JOURNAL OF NEUROSCIENCE (2015)
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
Stefano Espinoza et al.
NEUROPHARMACOLOGY (2015)
TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
Stefano Espinoza et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5
Juliane Dinter et al.
PLOS ONE (2015)
Trace Amine-Associated Receptor 1 Localization at the Apical Plasma Membrane Domain of Fisher Rat Thyroid Epithelial Cells Is Confined to Cilia
Joanna Szumska et al.
EUROPEAN THYROID JOURNAL (2015)
The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling
Juliane Dinter et al.
EUROPEAN THYROID JOURNAL (2015)
Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease
X. Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
Mark J. Millan
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease
Xiaoqun Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
D. Leo et al.
NEUROPHARMACOLOGY (2014)
Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
Lars Brichta et al.
FRONTIERS IN NEUROANATOMY (2014)
Rgs6 is Required for Adult Maintenance of Dopaminergic Neurons in the Ventral Substantia Nigra
Panojot Bifsha et al.
PLOS GENETICS (2014)
Dissecting the diversity of midbrain dopamine neurons
Jochen Roeper
TRENDS IN NEUROSCIENCES (2013)
GIRK2 Expression in Dopamine Neurons of the Substantia Nigra and Ventral Tegmental Area
Stefanie Reyes et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2012)
Trace Amine Associated Receptor 1 Signaling in Activated Lymphocytes
Michael W. Panas et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons
Sarah Threlfell et al.
NEURON (2012)
Brain-Specific Overexpression of Trace Amine-Associated Receptor I Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
Florent G. Revel et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1
Cindy Achat-Mendes et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Tyrosine hydroxylase and regulation of dopamine synthesis
S. Colette Daubner et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)
Henri Stalder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity
Gregory M. Miller
JOURNAL OF NEUROCHEMISTRY (2011)
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
Benjamin Di Cara et al.
JOURNAL OF NEUROSCIENCE (2011)
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza et al.
MOLECULAR PHARMACOLOGY (2011)
Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists
Gunnar Kleinau et al.
PLOS ONE (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Striatal Transporter for Dopamine: Catechol Structure-Activity Studies and Susceptibility to Chemical Modification
Susan M. Meiergerd et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Effect of β-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex
Mikio Murata et al.
BRAIN RESEARCH (2009)
Modulation of cardiac ionic homeostasis by 3-iodothyronamine
Sandra Ghelardoni et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Central effects of thyronamines on glucose metabolism in rats
Lars P. Klieverik et al.
JOURNAL OF ENDOCRINOLOGY (2009)
A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Trace Amine-Associated Receptors as Emerging Therapeutic Targets
Tatyana D. Sotnikova et al.
MOLECULAR PHARMACOLOGY (2009)
Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation
Hongshi Qi et al.
NEUROPHARMACOLOGY (2009)
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
Amyaouch Bradaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
β-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1:: Implication for modulatory roles of trace amines in brain
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Trace amine associated receptor 1 and movement control
Tatyana D. Sotnikova et al.
PARKINSONISM & RELATED DISORDERS (2008)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Trace amine-associated receptor 1 - Family archetype or iconoclast?
David K. Grandy
PHARMACOLOGY & THERAPEUTICS (2007)
The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. D. Wolinsky et al.
GENES BRAIN AND BEHAVIOR (2007)
Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury
Kristian P. Doyle et al.
STROKE (2007)
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function
Grazia Chiellini et al.
FASEB JOURNAL (2007)
Rhesus monkey trace amine-associated receptor 1 signaling: Enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Trace amine-associated receptor 1 is a modulator of the dopamine transporter
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Tyramine excites rat subthalamic neurons in vitro by a dopamine-dependent mechanism
Zi-Tao Zhu et al.
NEUROPHARMACOLOGY (2007)
The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
M. D. Berry
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Trace amine-associated receptors and their ligands
R. Zucchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain
Scott A. Burchett et al.
PROGRESS IN NEUROBIOLOGY (2006)
Trace amine-associated receptor agonists: Synthesis and evaluation of thyronamines and related analogues
ME Hart et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Primate trace amine receptor 1 modulation by the dopamine transporter
GM Miller et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Trace amines depress GABAB response in dopaminergic neurons by inhibiting G-βγ-gated inwardly rectifying potassium channels
M Federici et al.
MOLECULAR PHARMACOLOGY (2005)
Inhibitory effects of trace amines on rat midbrain dopaminergic neurons
R Geracitano et al.
NEUROPHARMACOLOGY (2004)
The thalamostriatal system: a highly specific network of the basal ganglia circuitry
Y Smith et al.
TRENDS IN NEUROSCIENCES (2004)
Tyrosine hydroxylase phosphorylation: regulation and consequences
PR Dunkley et al.
JOURNAL OF NEUROCHEMISTRY (2004)
3-iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
TS Scanlan et al.
NATURE MEDICINE (2004)
Dopamine transporter-dependent and -independent actions of trace amine β-phenylethylamine
TD Sotnikova et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Trace amine receptors as targets for novel therapeutics: legend, myth and fact
TA Branchek et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
LB Li et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
JR Bunzow et al.
MOLECULAR PHARMACOLOGY (2001)
Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B
DP Holschneider et al.
BRAIN RESEARCH BULLETIN (2001)
Phenylethylamine, a possible link to the antidepressant effects of exercise?
A Szabo et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2001)
Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors
KL Pierce et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Trace amines: Identification of a family of mammalian G protein-coupled receptors
B Borowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum
N Lindgren et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Share Paper
